Literature DB >> 6206190

In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific.

A E Lukacher, V L Braciale, T J Braciale.   

Abstract

Cloned lines of murine cytotoxic T lymphocytes (CTL) directed to type A influenza virus confer complete protection upon adoptive transfer to syngeneic mice lethally infected by influenza virus. The exquisite specificity exhibited by a subtype-specific cloned CTL in culture is reflected in its capacity to eliminate pulmonary virus and mediate recovery only in those mice infected by the virus subtype recognized by this cloned line in vitro. A cross-reactive CTL cloned line protects mice infected by either of two influenza virus subtypes. In mice dually infected with two virus subtypes, the subtype-specific CTL clone only reduces lung virus levels of the recognized virus subtype and cannot prevent these mice from dying. In contrast, adoptive transfer of the cross-reactive CTL clone into mice simultaneously infected with two virus subtypes results in reduction of pulmonary titers of both subtypes and promotes complete recovery. These results directly implicate CTL as an important antiviral defense mechanism in experimental influenza infection. In addition, these results indicate that both the induction and expression of antiviral effector activity by CTL in vivo is highly specific and therefore favor the concept that CTL express their antiviral effect in vivo by direct cytolysis of infected cells.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6206190      PMCID: PMC2187390          DOI: 10.1084/jem.160.3.814

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  23 in total

1.  Role of T-cell function in recovery from murine influenza infection.

Authors:  K L Yap; T J Braciale; G L Ada
Journal:  Cell Immunol       Date:  1979-03-15       Impact factor: 4.868

2.  The recovery of mice from influenza virus infection: adoptive transfer of immunity with immune T lymphocytes.

Authors:  K L Yap; G L Ada
Journal:  Scand J Immunol       Date:  1978       Impact factor: 3.487

3.  Recovery from a viral respiratory infection. II. Passive transfer of immune spleen cells to mice with influenza pneumonia.

Authors:  M A Wells; F A Ennis; P Albrecht
Journal:  J Immunol       Date:  1981-03       Impact factor: 5.422

4.  Immune interferon release when a cloned cytotoxic T-cell line meets its correct influenza-infected target cell.

Authors:  A G Morris; Y L Lin; B A Askonas
Journal:  Nature       Date:  1982-01-14       Impact factor: 49.962

5.  Antigen-driven helper cell-independent cloned cytolytic T lymphocytes.

Authors:  M B Widmer; F H Bach
Journal:  Nature       Date:  1981-12-24       Impact factor: 49.962

6.  Recovery from a viral respiratory infection. I. Influenza pneumonia in normal and T-deficient mice.

Authors:  M A Wells; P Albrecht; F A Ennis
Journal:  J Immunol       Date:  1981-03       Impact factor: 5.422

7.  Increased susceptibility to cytomegalovirus infection in beige mutant mice.

Authors:  G R Shellam; J E Allan; J M Papadimitriou; G J Bancroft
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

8.  Cytotoxic T lymphocytes produce immune interferon in response to antigen or mitogen.

Authors:  J R Klein; D H Raulet; M S Pasternack; M J Bevan
Journal:  J Exp Med       Date:  1982-04-01       Impact factor: 14.307

9.  Biological properties of an influenza A virus-specific killer T cell clone. Inhibition of virus replication in vivo and induction of delayed-type hypersensitivity reactions.

Authors:  Y L Lin; B A Askonas
Journal:  J Exp Med       Date:  1981-08-01       Impact factor: 14.307

10.  Heterogeneity and specificity of cloned lines of influenza-virus specific cytotoxic T lymphocytes.

Authors:  T J Braciale; M E Andrew; V L Braciale
Journal:  J Exp Med       Date:  1981-04-01       Impact factor: 14.307

View more
  154 in total

1.  Impairment of antigen-specific cellular immune responses under simulated microgravity conditions.

Authors:  K J Sastry; P N Nehete; C A Savary
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001-04       Impact factor: 2.416

2.  Diversity of T-cell receptors in virus-specific cytotoxic T lymphocytes recognizing three distinct viral epitopes restricted by a single major histocompatibility complex molecule.

Authors:  Y Yanagi; A Tishon; H Lewicki; B A Cubitt; M B Oldstone
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

3.  Mutation of human immunodeficiency virus type 1 at amino acid 585 on gp41 results in loss of killing by CD8+ A24-restricted cytotoxic T lymphocytes.

Authors:  L C Dai; K West; R Littaua; K Takahashi; F A Ennis
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

Review 4.  Role of class I molecules of the major histocompatibility complex in cytotoxic T-cell function in health and disease.

Authors:  A J McMichael
Journal:  Springer Semin Immunopathol       Date:  1992

5.  Immunogenic properties of ISCOM prepared with influenza virus nucleoprotein.

Authors:  H P Weiss; L Stitz; H Becht
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

6.  The magnitude of the T cell response to a clinically significant dose of influenza virus is regulated by TRAIL.

Authors:  Erik L Brincks; Prajwal Gurung; Ryan A Langlois; Emily A Hemann; Kevin L Legge; Thomas S Griffith
Journal:  J Immunol       Date:  2011-09-21       Impact factor: 5.422

Review 7.  Aging, cytomegalovirus (CMV) and influenza vaccine responses.

Authors:  Daniela Frasca; Bonnie B Blomberg
Journal:  Hum Vaccin Immunother       Date:  2016-03-03       Impact factor: 3.452

Review 8.  T cell memory in the lung airways.

Authors:  David L Woodland; Iain Scott
Journal:  Proc Am Thorac Soc       Date:  2005

9.  CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection.

Authors:  M Matloubian; R J Concepcion; R Ahmed
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

10.  Cross-reactive lysis of human targets infected with prototypic and clinical human immunodeficiency virus type 1 (HIV-1) strains by murine anti-HIV-1 IIIB env-specific cytotoxic T lymphocytes.

Authors:  S Chada; C E DeJesus; K Townsend; W T Lee; L Laube; D J Jolly; S M Chang; J F Warner
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.